Dystonia, Essential Tremor, Parkinson Disease
Conditions
Brief summary
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Detailed description
The purpose of this study is to characterize 1\. real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Interventions
DEVICEDeep Brain Stimulation
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
Sponsors
Boston Scientific Corporation
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Must be previously treated with or eligible for implantation with a deep brain stimulation system
Exclusion criteria
* No
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline | 5 yrs. post implant | Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline |
Countries
Belgium, France, Germany, Italy, Spain, United States
Contacts
CONTACTCleo Mertz
CONTACTDiane Keesey
STUDY_DIRECTORNatalie Bloom Lyons
Boston Scientific Neuromodulation Corporation
Outcome results
None listed